Hi all,

Just did a quick update to the resources list at the top of the sub to add most of the suggestions I got in the comments. The new additions (mostly in the "GENERAL STOCK MARKET RESEARCH" category, but also added some in the Fundamental Analysis section and the blogs/misc resources section) Here are some of the new additions – thanks for all the suggestions! Bolded ones are ones I have used myself and just missed adding in the first post.

• Finviz – Lots of free research tools (Not sure how I missed that one lol)
• Barchart – Technical and Fundamental Analysis Tools
• Koyfin – Free Comprehensive Market Data for Investors
• The Market Ear – Live Market News/Analysis
• IPOScoop – Lots of handy info on IPOs
• Stockrow – News, Fundamental Data and Screeners
• Stock Analysis – Free Online Stock Information for Investors
• BioPharmCatalyst – Biotech-Specific Research
• Macrotrends – The Long Term Perspective on Markets
• Atom Finance
• Vhinny – Consolidated Financial Statements and Fundamentals
• Docoh – SEC Filing & Company Analysis
• Beeken – Investing Tools Reimagined
• Stockrow Screener
• Polygon – APIs for Stocks, Forex and Crypto

Click here for the full list or just check out the original post at the top of the sub. Have fun tinkering w/ everything all weekend!

I went to the WSJ, yahoo finance, ATOM (app), and macrotrends and some have different numbers for some items on the income statements for Jetblue. How is that possible? I thought that info would be wildly accurate across platforms.

Pfizer and German partner BioNTech SE said on Tuesday they have begun delivering doses of their coronavirus vaccine candidates for initial human testing in the United States. Trials in Germany had already begun.

If successful, Pfizer said it hopes to receive emergency use authorization from the U.S. Food and Drug Administration as early as October. It could distribute up to 20 million doses by the end of 2020, and potentially hundreds of millions next year, it said.

[Source: Reuters found via Beeken io]

Definitely one to watch.